Variants | Non-IL N (%) | LSIL N (%) | OR (CI 95%) P | HSIL N (%) | OR (CI 95%) P | SCC N (%) | OR (CI 95%) p | ADC N (%) | OR (CI 95%) P | Other epithelial tumor N (%) | Cervical carcinoma N (%) | OR (CI 95%) P |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Class E-T350a | 23 (23.71%) | 23 (18.7%) | - | 1 (5.26%) | - | 4 (5.26%) | - | 0 (0%) b | - | 0 (0.0%) | 4 (4.40%) | - |
E-Prototype | 17 (17.53%) | 23 (18.7%) | 1* | 1 (5.26%) | 1* | 2 (2.63%) | 1* | 0 (0%)b | 1* | - | 2 (2.2%) | 1* |
Class E-G350 | 64 (65.98%) | 85 (69.11%) | 0.97 | 3.73 | 12.66 | 2.42 | 14.12 | |||||
0.47-1.99 | 14 (73.68%) | 0.46-30.44 | 49 (64.47%) | 1.89-84.92 | 7 (53.85%) | 0.25-∞ | 1 (50.0%) | 57 (62.65%) | 2.19-90.97 | |||
0.94 | 0.22 | 0.009 | 0.44 | 0.005 | ||||||||
E-G350 | 39 (40.21%) | 56 (45.53%) | 1.01 | 2.58 | 12.56 | 1.74 | 13.25 | |||||
0.47-2.17 | 6 (31.58%) | 0.29-23.17 | 28 (36.84%) | 1.84-85.86 | 3 (23.08%) | 0.15-∞ | - | 31 (34.07%) | 2.02-87.12 | |||
0.98 | 0.39 | 0.010 | 0.65 | 0.007 | ||||||||
E-A176/G350 | 3 (3.09%) | 5 (4.07%) | 1.49 | 5.82 | 24.79 | 12.62 | 39.82 | |||||
0.31-7.23 | 1 (5.26%) | 0.28-121.37 | 5 (6.58%) | 2.33-263.35 | 2 (15.38%) | 0.79-∞ | 1 (50.0%) | 8 (8.79%) | 4.11-386.04 | |||
0.62 | 0.26 | 0.008 | 0.07 | 0.001 | ||||||||
E-C188/G350 | 11 (11.34%) | 13 (10.57%) | 1.0 | 7.91 | 8.56 | 3.05 | 10.48 | |||||
0.35-2.84 | 5 (26.32%) | 0.81-77.58 | 8 (10.53%) | 1.07-68.26 | 2 (15.38%) | 0.23-∞ | - | 10 (10.99%) | 1.39-78.92 | |||
0.99 | 0.08 | 0.043 | 0.40 | 0.023 | ||||||||
Class AA-a | 4 (4.12%) | 11 (8.94%) | 2.18 | 12.65 | 35.21 | 21.24 | 54.51 | |||||
0.58-8.17 | 3 (15.79%) | 1.02-156.20 | 12 (15.79%) | 3.87-320.39 | 5 (38.46%) | 1.75-∞ | 1 (50.0%) | 18 (19.78%) | 6.36-467.62 | |||
0.25 | 0.048 | 0.002 | 0.016 | 0.000 | ||||||||
AA-a | 3 (3.09%) | 11 (8.94%) | 3.08 | 17.40 | 43.73 | 26.69 | 69.01 | |||||
0.73-13.04 | 3 (15.79%) | 1.32-229.60 | 12 (15.79%) | 4.55-420.56 | 5 (38.46%) | 2.10-∞ | 1 (50.0%) | 18 (19.78%) | 7.57-628.96 | |||
0.13 | 0.03 | 0.001 | 0.01 | 0.000 | ||||||||
Class AA-c | 6 (6.19%) | 3 (2.44%) | 0.44 | 2.79 | 24.46 | 3.01 | 25.28 | |||||
0.10-2.06 | 1 (5.26%) | 0.15-52.20 | 11 (14.47%) | 2.89-207.12 | 1 (7.69%) | 0.15-∞ | - | 12 (13.19%) | 3.12-204.74 | |||
0.30 | 0.49 | 0.003 | 0.47 | 0.002 | ||||||||
AA-c | 6 (6.19%) | 3 (2.44%) | 0.46 | 2.93 | 19.97 | 2.99 | 21.16 | |||||
0.10-2.15 | 1 (5.26%) | 0.16-54.90 | 9 (11.84%) | 2.34-170.25 | 1 (7.69%) | 0.15-∞ | - | 10 (10.99%) | 2.59-172.56 | |||
0.32 | 0.47 | 0.006 | 0.47 | 0.004 | ||||||||
Class Af2-a | 0 (0%) | 1 (0.81%) | - | 0 (0%) | - | 0 (0%) | - | 0 (0%) | - | 0 (0%) | 0 (0%) | - |